A cutting edge therapeutic for modern regenerative medicine. Our recombinant protein reverses the most common complication after a myocardial infarction: scar tissue formation that weakens the heart and leads to progressive heart failure.
Investors 1
| Date | Name | Website |
| - | MBC BioLab... | mbcbiolabs... |
Mentions in press and media 1
| Date | Title | Description | Category | Author | Source |
| 28.03.2022 | Explore In... | Today’s standard of care for t... | - | - | prweb.com/... |